1 Min Read
Dec 1 (Reuters) - Biostage Inc :
* Biostage receives FDA orphan drug designation for cellspan esophageal implant Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.